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Though obesity is an established risk factor for gall bladder cancer, its role in cancers of the extrahepatic bile ducts and ampulla of
Vater is less clear, as also is the role of abdominal obesity. In a population-based case–control study of biliary tract cancer in Shanghai,
China, odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for biliary tract cancer in relation to anthropometric
measures, including body mass index (BMI) at various ages and waist-to-hip ratio (WHR), adjusting for age, sex, and education. The
study included 627 patients with biliary tract cancer (368 gall bladder, 191 bile duct, 68 ampulla of Vater) and 959 healthy subjects
randomly selected from the population. A higher BMI at all ages, including early adulthood (ages 20–29 years), and a greater WHR
were associated with an increased risk of gall bladder cancer. A high usual adult BMI (X25.0) was associated with a
1.6-fold risk of gall bladder cancer (95% CI 1.2–2.1, P for trend o0.001). Among subjects without gallstones, BMI was also positively
associated with gall bladder cancer risk. Regardless of BMI levels, increasing WHR was associated with an excess risk of gall bladder
cancer risk, with those having a high BMI (X25) and a high WHR (40.90) having the highest risk of gall bladder cancer (OR¼12.6,
95% CI 4.8–33.2), relative to those with a low BMI and WHR. We found no clear risk patterns for cancers of the bile duct and
ampulla of Vater. These results suggest that both overall and abdominal obesity, including obesity in early adulthood, are associated
with an increased risk of gall bladder cancer. The increasing prevalence of obesity and cholesterol stones in Shanghai seems at least
partly responsible for the rising incidence of gall bladder cancer in Shanghai.
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Biliary tract cancers, which include cancers of the gall bladder,
extrahepatic bile duct, and ampulla of Vater, are rare but highly
fatal (Hsing et al, 2006). Apart from gallstones, the aetiology of
biliary cancers is obscure (Wistuba and Gazdar, 2004; Hsing et al,
2007c). Obesity is closely linked to both gallstones and gall bladder
cancer (Jorgensen, 1989; Kato et al, 1992; Stampfer et al, 1992;
Hsing et al, 2006), although its relationship with other biliary
cancers is less clear. It is also unclear at what age excess body fat
most affects disease risk, as measurements of body size have been
mainly related to a single point in time, and whether obesity
independently influences biliary cancer risk, given the close
connection between obesity and gallstone risk and between
gallstones and biliary tract cancer. In addition, the role of
abdominal obesity or body fat distribution in biliary tract cancer
are unclear, although abdominal obesity is more closely associated
with lipid and hormone metabolism (Giorgino et al, 2005).
Thus, to clarify further the role of overall and abdominal obesity
in biliary tract cancer, in a large population-based case–control
study in Shanghai, China, we have examined the roles of body
mass index (BMI), both usual (adult) and at various time points in
life, and waist-to-hip ratio (WHR).
MATERIALS AND METHODS
The study protocol was approved by the Institutional Review
Boards of the US National Cancer Institute (NCI) and the Shanghai
Cancer Institute (SCI). Details of the study have been reported
elsewhere (Hsing et al, 1998, 2007a,b,c,d). Patients with primary
biliary cancer (ICD-9, 156) newly diagnosed between June 1997
and May 2001 were identified through a rapid-reporting system
established between the Shanghai Cancer Institute and 42
collaborating hospitals in urban Shanghai. Judging from incidence
data reported to the Shanghai Cancer Registry, this system
captured over 95% of all biliary cancer cases diagnosed within
the study period. Both independent and consensus review of
histologic data by expert pathologists positively confirmed the
reported diagnoses for more than 70% of the cancer cases. The
remaining cancer cases were confirmed through clinical review of Received 16 May 2008; revised 25 July 2008; accepted 25 July 2008
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ymedical imaging data from computed tomography, magnetic
resonance imaging, ultrasonography, or endoscopic retrograde
cholangiopancreatography. In addition, healthy individuals were
randomly chosen as population controls, frequency-matched on
the age and sex of the cancer case, using the demographic
information recorded on the personal registration cards of the
Shanghai Resident Registry.
In-person interviews were conducted using a structured
questionnaire to elicit information on potential risk factors,
including demographic characteristics, cigarette and alcohol use,
medical history, diet, and family history of cancer. All interviews
were tape-recorded and reviewed to verify that these data were
recorded accurately and to ensure that each interview was
conducted properly. In addition, 5% of the study subjects were
randomly selected and re-interviewed, with a concordance rate of
over 90% on responses to key questions across the two interviews.
Of those eligible, 627 cancer patients and 959 population control
subjects agreed to participate and provided written informed
consent at enrollment, a response rate of over 90% for cases and
82% for controls. Among participating controls, 85% also
consented to abdominal ultrasound screening for gallstone
detection. Individuals were defined as having biliary stones if they
had previously undergone cholecystectomy or had gallstones.
At the interview, subjects were asked for their adult height,
current weight; usual weight 5 years before interview, usual weight
during specific age decades (i.e., at ages 20–29, 30–39, 40–49, 50–
59 years), maximum adult weight (excluding pregnancy weight, for
women), age at and duration of maximum weight, main area of
weight gain on the body, and history of adult weight cycling
(X7kg gain or loss). Physical measurements of standing height,
weight, and waist and hip circumference were also taken at the
interview. Each measure was taken two times. When the difference
between the two measurements exceeded predetermined tolerance
limits (height, 2cm; weight, 1kg; waist and hip circumference,
2cm), an additional measurement was taken. Final measurements
for height, weight, and waist and hip circumference were
determined by averaging the two closest values.
Statistical analysis
BMI, weight in kilograms divided by the square of height in meters
(kg/m
2), was used to assess overall obesity. Self-reported data were
used to calculate BMI at specific age periods and maximum adult
BMI, respectively. The change in BMI over time, defined as the
difference in BMI between age intervals (e.g., from the ages 20–29
to 30–39 years), was also computed. Subjects were classified into
the BMI categories established by the World Health Organization
(WHO) for Asian populations, with the BMI category of 18.5–
22.9kg/m
2, defined as ‘normal’ and used as the reference group
(WHO, 2000). Body mass index categories of ‘overweight’ (23.0–
24.9) and ‘obesity’ (X25) were combined when the number of
cases in either category was small. For other anthropometric
measures, such as height and BMI change, subjects were
categorized according to either the tertile or quartile distributions
of the controls. WHR, waist circumference divided by hip
circumference, was used as a measure of abdominal adiposity.
As bile duct and ampulla of Vater cases are diagnosed at a late
stage, data on waist and hip circumference are less reliable, and
WHR was not computed for these two subsites.
Unconditional logistic regression was used to calculate odds
ratios and 95% confidence intervals for each cancer subsite
associated with BMI and other anthropometric measures, adjust-
ing for age, sex, and education. Gall bladder cancer patients were
compared with controls without a history of cholecystectomy
(n¼49), whereas patients with bile duct or ampullary cancer were
compared with all control subjects. Additional covariates, includ-
ing cigarette smoking, alcohol use, and history of diabetes and
Table 1 Selected characteristics of study subjects by case–control status, Shanghai, China
Cancer cases
Population controls
Gall bladder Bile duct ampulla of Vater All
N (%) N (%) N (%) N (%)
Total 368 (100.0) 191 (100.0) 68 (100.0) 959 (100.0)
Sex
Male 99 (26.9)
a 99 (51.8)
b 37 (54.4)
b 373 (38.9)
Female 269 (73.1) 92 (48.2) 31 (45.6) 586 (61.1)
Age at interview
34–44 19 (5.1) 6 (3.1) 1 (1.5) 41 (4.3)
45–54 30 (8.2) 24 (12.6) 5 (7.4) 87 (9.1)
55–64 96 (26.1) 47 (24.6) 20 (29.4) 269 (28.0)
65–74 223 (60.6) 114 (59.7) 42 (61.8) 562 (58.6)
Mean (SD) 64.2 (8.5) 63.6 (8.4) 65.2 (7.1) 63.9 (8.4)
Education
None/primary 198 (53.8)
a 86 (45.0) 29 (42.7) 396 (41.3)
Junior middle 79 (21.5) 43 (22.5) 16 (23.5) 233 (24.3)
Senior middle 50 (13.6) 31 (16.2) 15 (22.1) 190 (19.8)
Some college 41 (11.1) 30 (15.7) 8 (11.8) 140 (14.6)
Cigarette use
c 89 (24.2)
a 76 (39.8)
b 30 (44.1)
b 285 (29.7)
Alcohol consumption
d 52 (14.1)
a 50 (26.2) 15 (22.1) 198 (20.7)
History of hypertension 138 (37.5) 61 (31.9)
b 20 (29.4)
b 406 (42.3)
History of diabetes 51 (13.9)
a 20 (10.5) 5 (7.4) 78 (8.1)
Biliary stones 308 (83.7)
a 127 (66.5)
b 36 (52.9)
b 224 (23.4)
aCompared with population controls with no prior cholecystectomy, Po0.05.
bCompared with all population controls, Po0.05.
cHistory of at least one cigarette per day for 6 or
more months.
dConsumption of alcohol at least once a week for 6 or more months.
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but were not included in the final models, as they did not
appreciably change the risk estimates. Sex-specific analyses were
performed to evaluate differences between men and women in risk
associated with body size. Tests for linear trend in risks of cancer
were conducted when appropriate, with anthropometric variables
evaluated on a continuous scale. All tests were two-sided, with
Po0.05 defined as statistically significant.
RESULTS
Table 1 shows selected characteristics of study subjects. As shown,
more women were diagnosed with gall bladder cancer than men,
whereas slightly more men were diagnosed with cancers of the
extrahepatic bile duct and ampulla of Vater. Cases and controls
were similar in age. Relative to controls, patients with gall bladder
cancer were less educated. Gall bladder cancer case patients were
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) for biliary tract cancer in relation to anthropometric measures
Gall bladder
cancer (N¼368)
Extrahepatic bile duct
cancer (N¼191)
ampulla of Vater
cancer (N¼68)
Anthropometry
(Quartile)
a N1/N2
b OR
c 95 % CI Ptrend
Anthropometry
a
(Tertile) N3/N4/N5
d OR
c 95 % CI Ptrend OR
c 95% CI Ptrend
Height (cm) Reported height (cm)
p156 243/114 1.0 — p158
156–162 254/117 1.11 0.81–1.52 159–165 355/56/24 1 — 1 —
163–168 208/68 1.12 0.75–1.68 4165 310/65/16 1.08 0.70–1.67 0.58 0.27–1.23
4168 197/67 1.8 1.03–3.16 0.11 294/68/28 0.79 0.44–1.42 0.47 0.65 0.25–1.67 0.36
Usual adult BMI (kg/m
2) Usual adult
BMI (kg/m
2)
o18.5 78/17 0.62 0.35–1.09
18.5–22.9 390/130
184/73
1— o18.5 79/8/1 0.52 0.24–1.13 — —
23.0–24.9 249/145 1.2 0.85–1.68 18.5–22.9 404/86/29 1 — 1 —
X25 1.56 1.17–2.10 o0.001 X23.0 475/95/38 0.99 0.71–1.37 0.29 1.16 0.70–1.93 0.1
Maximum adult BMI (kg/m
2) Maximum adult BMI
o18.5 17/6 1.24 0.47–3.29
18.5–22.9 259/74 1 — o18.5 17/2/0 0.58 0.13–2.63 — —
23.0–24.9 212/83 1.35 0.94–1.95 18.5–22.9 266/55/21 1 — 1 —
X25.0 397/185 1.48 1.08–2.03 0.02 X23.0 659/123/44 0.91 0.64–1.30 0.84 0.89 0.52–1.54 0.94
BMI over time (kg/m
2)
Ages 20–29 (years) Ages 20–29 (years)
o18.5 227/61 0.73 0.53–1.02
18.5–22.9 533/199 1 — o18.5 240/25/5 0.52 0.33–0.82 0.26 0.10–0.66
23.0–24.9 19/16 1.46 0.94–2.25 18.5–22.9 563/119/47 1 — 1 —
X25.0 65/39 2.03 1.02–4.06 o0.001 X23.0 95/20/13 1.07 0.63–1.82 0.01 1.02 0.44–2.35 0.01
Ages 30–39 (years) Ages 30–39 (years)
o18.5 124/36 0.95 0.63–1.43
18.5–22.9 526/162 1 — o18.5 132/16/2 0.64 0.36–1.12 0.2 0.05–0.86
23.0–24.9 126/77 1.9 1.35–2.66 18.5–22.9 557/112/45 1 — 1 —
X25.0 60/42 1.97 1.27–3.06 o0.001 X23.0 200/31/13 0.82 0.53–1.27 0.67 0.91 0.47–1.74 0.13
Ages 40–49 (years) Ages 40–49 (years)
o18.5 74/18 0.74 0.43–1.29
18.5–22.9 443/144 1 — o18.5 77/8/0 0.57 0.26–1.22 — —
23.0–24.9 150/68 1.37 0.97–1.94 18.5–22.9 465/89/35 1 — 1 —
X25.0 126/72 1.6 1.13–2.27 0.001 X23.0 302/49/19 0.89 0.60–1.30 0.68 0.9 0.50–1.62 0.24
Ages 50–59 (years) Ages 50–59 (years)
o18.5 49/11 0.65 0.32–1.32
18.5–22.9 312/100 — o18.5 50/6/1 0.69 0.28–1.70 0.3 0.04–2.27
23.0–24.9 1 1.19 0.80–1.75 18.5–22.9 329/62/25 1 — 1 —
X25.0 102/156 1.88 1.33–2.64 o0.001 X23.0 328/59/24 1 0.67–1.48 0.62 1.01 0.56–1.82 0.44
BMI change in
adulthood
d
BMI change in
adulthood
c
p0.74 211/74 1 — p1.66 298/64/22 1 — 1 —
0.75–2.77 211/62 0.93 0.62–1.39 1.67–4.20 295/51/17 0.86 0.57–1.30 0.81 0.42–1.57
2.78–5.21 211/86 1.45 0.98–2.14 0.01 44.20 305/49/20 0.88 0.58–1.34 0.54 1.09 0.57–2.09 0.82
45.21 211/93 1.47 1.00–2.16
Waist to hip Ratio
e
p0.81 228/38 1 —
0.81–0.852 228/51 1.38 0.87–2.20
0.853–0.897 223/90 2.71 1.76–4.18
40.897 223/133 4.72 3.08–7.23 o0.0001
aFor categories of height and BMI change, quartile and tertile cutoff points (quartile or tertile) were based on their distribution among population controls without
cholecystectomy.
bN1 controls without a history of cholecystectomy, N2 gall bladder cancer cases, N3 controls, N4 extrahepatic bile duct cancer cases, N5 ampulla of Vater
cases.
cAdjusted for age (continuous), sex (male, female), and education (none/primary, junior middle, senior, and some college).
dChange between usual adult BMI and BMI at
ages 20–29 years; Also adjusted for BMI at ages 20–29 years.
eWHR was not computed for extrahepatic bile duct or ampulla of Vater cancers.
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control subjects, whereas smoking was more common among
those with bile duct and ampullary cancers. Cancer patients were
more likely to have gallstones and diabetes.
Table 2 shows the risk of biliary cancer by subsite in relation to
body size. Quartile cutoffs were used for gall bladder cancer,
whereas tertiles were used for extrahepatic bile duct and ampulla
of Vater cancers because of their smaller numbers of cases. All
BMI-related variables were positively associated with gall bladder
cancer risk, after adjustment for age, gender, and education level.
BMI in early adulthood (ages 20–29 years) remained significant
after adjustment for gallstones (OR¼2.04, 95% CI: 0.9–4.8, P for
trend¼0.01) or among subjects without gallstones (OR¼3.7, 95%
CI 1.1–12.1) (data not shown). Although larger waist circumfer-
ence was only slightly associated with an increased risk of gall
bladder cancer, a high WHR (40.897) was associated with a
4.7-fold risk (95% CI 3.1–7.2, P for trend o0.0001). There was no
clear association with cancers of the extrahepatic bile duct or
ampulla of Vater. Timing and duration of maximum adult weight,
primary location of weight gain, and weight cycling did not appear
to be related to risk for stones or cancer (data not shown),
although too few subjects reported a history of weight cycling for
reliable assessment.
Table 3 presents gall bladder cancer risk cross-classified by
four levels (quartiles) of BMI and three levels (tertiles) of
WHR. Regardless of BMI similarly increasing levels of WHR were
strongly associated with excess risk of gall bladder cancer, with
WHR having a greater impact than BMI. The highest risk is seen
for subjects with both a high BMI and a high WHR, with those in
the highest categories of BMI (X25) and WHR (40.87) having an
8.3-fold risk of gallstones (95% CI 4.6–14.9) and a 12.6-fold risk of
gall bladder cancer (95% CI 4.8–33.2), relative to subjects with
a low BMI and WHR.
DISCUSSION
In this population-based study, WHR and BMI at all ages,
including early adulthood, were associated with an increased risk
of gall bladder cancer. These results suggest that both overall and
abdominal obesity play an important role in the aetiology of gall
bladder cancer. It seems likely that the increasing prevalence of
obesity and cholesterol stones in Shanghai is at least partly
responsible for the rising incidence of gall bladder cancer in
Shanghai. These findings for gall bladder cancer are consistent
with those of previous studies (Zatonski et al, 1997; Wolk et al,
2001; Calle et al, 2003; Samanic et al, 2004; Engeland et al, 2005).
We found that the effect of obesity on gall bladder cancer is not
mediated entirely by gallstones, as the BMI effect persisted after
adjustment for gallstones. Among those without gallstones, BMI is
also associated with gall bladder cancer risk. However, it should be
noted that the statistical power for analysis stratified by gallstones
was limited, since less than 20% of the gall bladder cancer patients
had no history of stones and less than 25% of the controls had a
history of stones. Although gallstones are closely linked to both
BMI and gall bladder cancer, in assessing the effect of BMI, it may
not be necessary to adjust for gallstones, which are thought to be
an important factor in the causal pathway. Thus, adjustment for
gallstones would attenuate the true association between obesity
and biliary cancer risk. However, the gallstone-adjusted results
suggest that obesity may also increase the risk of gall bladder
cancer through pathways not related to gallstone pathogenesis. In
addition to affecting lipid metabolism, obesity can affect the risk of
gallstones and gall bladder cancer through adverse changes in the
metabolism of endogenous hormones, including sex steroids, sex
hormone-binding globulin, insulin growth factor-I, and inflammatory
mediators, such as insulin and cytokines; all of these stimulate cell
proliferation and inhibit apoptosis, thereby enhancing the
potential for tumour growth (Coussens and Werb, 2002).
Despite the fact that our study is the largest population-based
study to date, we found no clear association between obesity and
cancer of the bile duct or ampulla of Vater, possibly because of
their small numbers. Of the five available studies assessing bile
duct cancer risk specifically (Chow et al, 1994, 1999; Samanic et al,
2004; Oh et al, 2005), one reported an increased risk in white men
but not white women, two small studies reported no association
between obesity and ampullary cancer (Chow et al, 1999), whereas
one large study showed elevated risk of ampullary cancer in US
black men (Samanic et al, 2004). In two studies, tumours of the
extrahepatic bile duct and/or the ampulla of Vater were combined
with gall bladder cancer and were not evaluated separately (Lew
and Garfinkel, 1979; Engeland et al, 2005). As molecular and
epidemiologic studies suggest that these three subsites have
different aetiologies, future studies should evaluate the role of
obesity in extrahepatic bile duct and ampulla of Vater separately
from gall bladder cancer.
In this report, we used the WHO-recommended BMI cutoffs for
Asians, as they have been shown to have different body
composition and bone density (Pan et al, 2004). It has also been
shown that at a much lower level of BMI, relative to Caucasians,
Asians have a high prevalence of diabetes, metabolic syndrome,
and other adverse outcomes, suggesting that lower BMI cutoffs
should be used for these relatively lean populations. Based on the
WHO Asian-specific cutoffs, the prevalence of obesity
(BMIX25kg/m
2) in the Shanghai population is 25% but it is only
4.1% if the conventional cutoffs (BMI 430kg/m
2) are used. It
should be noted that although median BMI in our population is
low (22.9kg/m
2), the prevalence of abdominal obesity (WHR40.9)
is quite high (50%).
The validity of our results hinges largely on the validity of self-
reported BMI, which appeared to be quite good, given the fact that,
among our population controls, self-reported current weight
correlated well with measured weight (r¼0.89, Po0.0001) and
there is a good correlation between reported BMI and measured
WHR, suggesting that misclassification by BMI is minimal. The
validity of recalling weight for each decade in adulthood is likely to
be lower than that of current weight. However, in our study
correlations between reported weights in various decades of life
Table 3 Odds ratios (ORs)
a and 95% confidence intervals (CIs) for gall bladder cancer in relation to BMI and WHR
BMI
b
o18.5 18.5–22.9 23.0–24.9 X25
WHR
c N1N2
d OR (95% CI) N1N2 OR (95% CI) N1N2 OR (95% CI) N1N2 OR (95% CI)
o0.82 (56/5) 1.0 (—) (144/27) 2.22 (0.81–6.11) (49/67) 1.65 (0.48–5.58) (56/6) 1.01 (0.29–3.56)
0.82–0.87 (12/4) 4.25 (0.97–18.6) (130/38) 3.87 (1.43–10.4) (59/21) 4.19 (1.46–11.9) (96/29) 3.70 (1.15–8.74)
40.87 (10/3) 4.37 (0.87–21.8) (114/44) 5.70 (2.1–15.4) (76/36) 7.54 (2.73–20.3) (97/92) 12.6 (4.77–33.2)
aAdjusted for age (continuous), sex (male, female), and education (none/primary, junior middle, senior, and some college).
bUsual adult BMI; Based on WHO cutoffs.
cWaist-to-
hip ratio: based on distribution among controls.
dN1 controls. N2 gall bladder cancer cases.
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differential in cases and controls.
Several strengths of the study should be noted. Selection bias
was minimal because of population-based design with high case
ascertainment and high participation rates. Misclassification of
cases was minimal, given the nearly complete confirmation of case
status, achieved by comprehensive pathology and clinical review.
As the largest study to date, we were able to investigate the role of
obesity by anatomic subsite.
One major limitation of our study is the potential disease effect
on the reporting and measurement of body size. As cancer can
cause wasting and weight loss, cases might be expected to have lower
body weight than controls. However, we found that cases actually had
a higher BMI than controls, suggesting that the weight, especially
usual adult weight, in our cases had not been greatly affected by
cancer. We cannot generalize our results to western populations,
because of the large differences in prevalence of obesity and the fact
that we were unable to evaluate the effect of BMIs greater than 30, as
only 4% of the controls had a BMI that large.
In summary, this population-based study in Shanghai confirmed
that overall obesity is an important risk factor for gall bladder
cancer and found that obesity in early adulthood and abdominal
obesity are also relevant. Given the epidemic of obesity worldwide
and the substantial burden of gallstones in most populations, a
strategy to slow down the rising obesity trend and to minimize the
burden of gallstones and biliary cancer would be important to
develop.
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